Clinical Trial Update: To Demonstrate the Relative Bioavailability Study of Promethazine HCl 50 mg Tablets Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 study designed to demonstrate the relative bioavailability of Promethazine HCl 50 mg tablets under fasting conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Promethazine HCl 50 mg tablets (promethazine hydrochloride)

Snippet

Sponsor: Sandoz | Conditions: Allergy | Phase 1 | Status: COMPLETED